
China's Top 10 Pain Medicine Hospitals (2023 Fudan Rankings)
May 01, 2026
China leads multidisciplinary pain medicine, blending neuromodulation, acupuncture, and pharmacogenomics, with the 2023 Fudan rankings of top pain hospitals.
China's pain medicine: a global leader in multidisciplinary care.
China has emerged as an innovator in pain medicine, integrating Eastern and Western approaches to become a global reference in:
Multimodal pain management combining neuromodulation, acupuncture, and pharmacogenomics.
The largest clinical volume of spinal cord stimulator implants in Asia.
The specialty focuses on functional restoration rather than symptomatic relief, with outcomes for chronic low back pain and cancer pain matching Western standards. China uniquely blends high-technology interventions with cost-effective traditional methods.
2023 top pain medicine hospitals in China
Reputation score 9.818. Specialties: cancer pain management, neuromodulation. Breakthrough: developed China's first comprehensive cancer pain algorithm integrating acupuncture and spinal cord stimulation.
Reputation score 7.701. Specialties: neuropathic pain, CRPS (complex regional pain syndrome). Innovation: created the Nanchang Protocol for diabetic neuropathy using pulsed radiofrequency.
Reputation score 5.896. Specialties: headache medicine, trigeminal neuralgia. Technology: first center in China to use VR-based pain distraction therapy nationwide.
Reputation score 4.792. Specialties: pediatric pain management, genetic pain disorders.
Reputation score 4.429. Specialties: minimally invasive spinal procedures, workplace injury rehabilitation. Program: developed China's first occupational pain prevention program for manufacturing workers.
Remaining ranking (hospital and reputation score):
West China Hospital, Sichuan University: 4.156.
Peking University Third Hospital: 3.065.
First Hospital of China Medical University: 1.753.
First Affiliated Hospital, Zhejiang University: 1.675.
10. First Affiliated Hospital of Zhengzhou University: 1.649.
Why this matters. China's pain medicine advances have reduced opioid dependence by 52% in chronic pain patients since 2018. Integrating traditional acupuncture with advanced neuromodulation creates unique, personalized treatment protocols.




